1. OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial). (1st June 2001) Authors: Keystone, E; Weinblatt, ME; Weisman, M; Furst, D; Paulus, H; Birbara, C; Fischkoff, S; Chartash, EK Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗